相关实验视频

Updated: Jun 28, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

工程免疫逃避性全原细胞免疫疗法

Karen E Martin^1,2, Quirin Hammer³, Karlo Perica^4,5

¹Precision Immunotherapy Alliance, The University of Oslo, Oslo, Norway.

Nature reviews. Immunology

|April 24, 2024

概括

全基细胞疗法提供了有前途的癌症治疗方法,但面临免疫排斥. 受病毒和癌症免疫规避启发的策略可以改善这些现成免疫疗法的持久性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

全基细胞免疫疗法为癌症治疗提供了可扩展和具有成本效益的方法.
与自身治疗相比,转移的全原性T细胞和自然杀手细胞 (NK细胞) 的免疫排斥限制了它们的临床疗效.
克服免疫排斥对于实现现成的基于细胞的癌症治疗的全部潜力至关重要.

研究的目的:

讨论设计异性T和NK细胞以逃避免疫排斥的策略.
探索病毒和癌症免疫逃生机制的使用,作为增强细胞治疗持久性的基础.
突出基因组编辑和合成生物学在开发先进的基于细胞的免疫疗法的作用.

主要方法:

审查病毒和癌细胞使用的免疫逃避机制.
讨论基因组编辑和合成生物学方法用于细胞工程.
在全原细胞疗法的背景下分析先天和适应性免疫反应.

主要成果:

识别可以适应全源细胞疗法的免疫逃避策略.
提高现成细胞产品的持久性和治疗窗口的潜力.
强调需要考虑宿主免疫反应,以获得成功的治疗结果.

结论:

具有免疫逃避性质的基因细胞工程是克服排斥障碍的关键.
病毒和癌症免疫逃生机制为增强细胞治疗持久性提供了宝贵的蓝图.
精密免疫疗法设计需要全面了解接受者的免疫反应,以最大限度地提高治疗效益.

更多相关视频

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...